- Animal Study Offers Hope for a Better Herpes Treatment
- Health Highlights: June 17, 2021
- $10,000: What New Parents Might Pay for Childbirth, Even With Insurance
- Living With HIV Raises Odds for Sudden Cardiac Death
- Less Than 1% of People Who’ve Had Severe COVID Get Re-Infected
- Fast-Food Companies Spending More on Ads Aimed at Youth
- How Secure Is Your Health or Fitness App?
- What Works Best to Ease Migraines?
- For Losing Weight, Calorie Counting Tops Fasting Diets
- Mold a Big Threat to People With COPD
HPV Test Beats Pap Smear for Cancer Screening
WEDNESDAY, April 28Doctors can detect more serious precancerous lesions in the cervix by testing for human papillomavirus (HPV) than through conventional cervical screening with a Pap smear, a new study suggests.
HPV, a common sexually transmitted disease, can cause cancers such as cervical cancer. The disease is especially prevalent in young women.
In the new study, led by Ahti Anttila of the Finnish Cancer Registry, researchers studied the experiences of 58,282 women aged 30 to 60 who took part in routine cervical screening between 2003 and 2005.
The women were randomly assigned to receive an HPV test or a Pap smear test. The researchers then tracked the women for five years.
The HPV screening tests did a better job at detecting serious precancerous lesions on the surface of the cervix, known as cervical intraepithelial neoplasia (CIN III), according to the report published online April 28 in the BMJ.
The researchers cautioned that they didn’t detect very many cervical cancer cases. Still, they wrote, “considering the high probability of progression of CIN III lesions in women aged 35 years or more, our results are important for prevention of cervical cancer.”
More information
The U.S. National Cancer Institute has more on cervical cancer.
Source: HealthDay
